What does CUSIP 29251M106 represent in this 13F holders report?

CUSIP 29251M106 is the security identifier for ENTA - ENANTA PHARMACEUTICALS INC - Common Stock used to aggregate holder disclosures.

How many institutions held ENTA - ENANTA PHARMACEUTICALS INC - Common Stock in Q2 2016?

126 institutional investors reported ENTA - ENANTA PHARMACEUTICALS INC - Common Stock for Q2 2016. Use the holders table for investor-level position and value details.

ENANTA PHARMACEUTICALS INC - Common Stock (ENTA)

CUSIP: 29251M106

Q2 2016 13F Holders as of 30 Jun 2016

Type / Class: Equity / Common Stock
Shares outstanding: 28,862,345
Total 13F shares: 13,419,466
Share change: +363,750
Total reported value: $295,897,870
Put/Call ratio: 89%
Price per share: $22.05
Number of holders: 126
Value change: -$1,389,083
Number of buys: 59
Number of sells: 83

Quarterly Holders Quick Answers

What is CUSIP 29251M106?
CUSIP 29251M106 identifies ENTA - ENANTA PHARMACEUTICALS INC - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2016
Previous quarter: Q1 2016

Recent filing periods for CUSIP 29251M106:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of ENTA - ENANTA PHARMACEUTICALS INC - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
Apex Capital Management	13F	Company	4.5%	1,292,751	$37,968,000	—	31 Mar 2016	13F
BlackRock Fund Advisors	13F	Company	4.1%	1,184,007	$34,774,000	—	31 Mar 2016	13F
EAGLE ASSET MANAGEMENT INC	13F	Company	3.4%	993,825	$29,188,000	—	31 Mar 2016	13F
Krensavage Asset Management, LLC	13F	Company	3.1%	882,529	$25,920,000	—	31 Mar 2016	13F
ACADIAN ASSET MANAGEMENT LLC	13F	Company	2.8%	807,874	$23,729,000	—	31 Mar 2016	13F
FMR LLC	13F	Company	2.2%	649,115	$19,065,000	—	31 Mar 2016	13F
VANGUARD GROUP INC	13F	Company	2.2%	631,489	$18,547,000	—	31 Mar 2016	13F
STATE STREET CORP	13F	Company	2%	581,552	$17,081,000	—	31 Mar 2016	13F
Granahan Investment Management, LLC	13F	Company	1.4%	416,425	$12,230,000	—	31 Mar 2016	13F
BlackRock Institutional Trust Company, N.A.	13F	Company	1.3%	374,196	$10,990,000	—	31 Mar 2016	13F
SENZAR ASSET MANAGEMENT, LLC	13F	Company	1.2%	338,851	$9,952,054	—	31 Mar 2016	13F
BANK OF AMERICA CORP /DE/	13F	Company	1.1%	327,032	$9,605,000	—	31 Mar 2016	13F
ORBIMED ADVISORS LLC	13F	Company	0.86%	249,400	$7,325,000	—	31 Mar 2016	13F
EcoR1 Capital, LLC	13F	Company	0.83%	240,383	$7,060,000	—	31 Mar 2016	13F
Bank of New York Mellon Corp	13F	Company	0.78%	224,180	$6,585,000	—	31 Mar 2016	13F
Matarin Capital Management, LLC	13F	Company	0.76%	219,036	$6,433,088	—	31 Mar 2016	13F
HAYS ADVISORY LLC	13F	Company	0.7%	200,926	$5,901,000	—	31 Mar 2016	13F
NORTHERN TRUST CORP	13F	Company	0.65%	186,373	$5,475,000	—	31 Mar 2016	13F
Aureus Asset Management, LLC	13F	Company	0.58%	166,546	$4,891,000	—	31 Mar 2016	13F
S.c.a. Candriam	13F	Individual	0.56%	162,000	$4,732,000	—	31 Mar 2016	13F
Skandinaviska Enskilda Banken AB (publ)	13F	Company	0.54%	156,400	$4,593,000	—	31 Mar 2016	13F
NEW YORK STATE COMMON RETIREMENT FUND	13F	Company	0.49%	140,850	$4,137,000	—	31 Mar 2016	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.45%	130,318	$3,827,000	—	31 Mar 2016	13F
GSA CAPITAL PARTNERS LLP	13F	Company	0.44%	126,675	$3,720,000	—	31 Mar 2016	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.44%	125,888	$3,698,000	—	31 Mar 2016	13F
OXFORD ASSET MANAGEMENT LLP	13F	Company	0.42%	122,457	$3,597,000	—	31 Mar 2016	13F
SEIZERT CAPITAL PARTNERS, LLC	13F	Company	0.41%	117,791	$3,460,000	—	31 Mar 2016	13F
McClain Value Management LLC	13F	Company	0.37%	106,508	$3,128,000	—	31 Mar 2016	13F
QS Investors, LLC	13F	Company	0.33%	95,916	$2,817,000	—	31 Mar 2016	13F
RUSSELL FRANK CO/	13F	Company	0.32%	93,781	$2,755,000	—	31 Mar 2016	13F
PRINCIPAL FINANCIAL GROUP INC	13F	Company	0.31%	90,825	$2,668,000	—	31 Mar 2016	13F
TIAA CREF INVESTMENT MANAGEMENT LLC	13F	Company	0.31%	88,848	$2,609,000	—	31 Mar 2016	13F
Gotham Asset Management, LLC	13F	Company	0.31%	88,631	$2,603,000	—	31 Mar 2016	13F
Numeric Investors LLC	13F	Company	0.31%	88,144	$2,589,000	—	31 Mar 2016	13F
AJO, LP	13F	Company	0.3%	87,716	$2,576,000	—	31 Mar 2016	13F
LANDSCAPE CAPITAL MANAGEMENT, L.L.C.	13F	Company	0.3%	85,258	$2,504,000	—	31 Mar 2016	13F
Tieton Capital Management, LLC	13F	Company	0.29%	85,115	$2,500,000	—	31 Mar 2016	13F
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	0.29%	83,016	$2,438,000	—	31 Mar 2016	13F
CORNERSTONE CAPITAL MANAGEMENT HOLDINGS LLC.	13F	Company	0.29%	82,851	$2,434,000	—	31 Mar 2016	13F
WELLS FARGO & COMPANY/MN	13F	Company	0.28%	81,150	$2,383,000	—	31 Mar 2016	13F
BAKER BROS. ADVISORS LP	13F	Company	0.26%	75,357	$2,213,000	—	31 Mar 2016	13F
Spark Investment Management LLC	13F	Company	0.25%	72,800	$2,138,000	—	31 Mar 2016	13F
Summit Street Capital Management, LLC	13F	Company	0.25%	71,675	$2,105,000	—	31 Mar 2016	13F
Invesco Ltd.	13F	Company	0.24%	69,754	$2,049,000	—	31 Mar 2016	13F
DEUTSCHE BANK AG\	13F	Company	0.23%	66,038	$1,938,000	—	31 Mar 2016	13F
BlackRock Investment Management, LLC	13F	Company	0.22%	63,694	$1,871,000	—	31 Mar 2016	13F
AMERIPRISE FINANCIAL INC	13F	Company	0.21%	61,145	$1,796,000	—	31 Mar 2016	13F
LPL Financial LLC	13F	Company	0.2%	59,030	$1,735,000	—	31 Mar 2016	13F
UNITED SERVICES AUTOMOBILE ASSOCIATION	13F	Company	0.2%	58,360	$1,714,000	—	31 Mar 2016	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.19%	55,600	$1,633,000	—	31 Mar 2016	13F

Institutional Holders of ENANTA PHARMACEUTICALS INC - Common Stock (ENTA) as of Q2 2016

As of 30 Jun 2016, ENANTA PHARMACEUTICALS INC - Common Stock (ENTA) was held by 126 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 13,419,466 shares. The largest 10 holders included BlackRock Fund Advisors, EAGLE ASSET MANAGEMENT INC, Krensavage Asset Management, LLC, FMR LLC, ACADIAN ASSET MANAGEMENT LLC, STATE STREET CORP, VANGUARD GROUP INC, Fiera Capital Corp, GREAT POINT PARTNERS LLC, and SENZAR ASSET MANAGEMENT, LLC. This page lists 126 institutional shareholders reporting positions in this security for the Q2 2016 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2016 vs Q1 2016 Across Filers

Q1 2016 holders

150

Q2 2016 holders

126

Holder diff

-24

Investor	Q1 2016 Shares	Q2 2016 Shares	Share Diff	Share Chg %	Q1 2016 Value $	Q2 2016 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.